Literature DB >> 22559023

Letter: Treatment-resistant pyoderma gangrenosum.

Payman Kosari, Steven R Feldman.   

Abstract

Pyoderma gangrenosum (PG) is an uncommon neutrophilic dermatosis that can have a chronic course often leading to ulceration and extreme tenderness. Treatment is often directed toward reducing the inflammatory process to prevent progression of the ulcer and minimize pain. The mainstay of therapy is systemic corticosteroids. Other immunosuppressants have been utilized in cases of PG resistant to corticosteroids, including cyclosporine and tacrolimus. A patient with severe and recalcitrant PG was prescribed systemic corticosteroids and cyclosporine but continued to have progression of her disease warranting admission to the hospital. Her hospital course was complicated requiring hospitalization for one month. Although her health was deteriorating, her PG improved in the hospital setting with corticosteroids without concomitant cyclosporine. The patient admitted to non-compliance with her medication in the outpatient setting, attributing her behavior mainly to depression. Pyoderma gangrenosum can be recalcitrant to any form of therapy and medication non-adherence must be considered a potential cause.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22559023

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  2 in total

1.  Extensive phlegmon and pyoderma gangrenosum: diagnostic difficulties.

Authors:  Dominika Wcisło-Dziadecka; Beata Bergler-Czop; Ligia Brzezińska-Wcisło; Hubert Arasiewicz
Journal:  Postepy Dermatol Alergol       Date:  2015-02-04       Impact factor: 1.837

2.  Pyoderma gangrenosum in a patient with common variable primary immunodeficiency.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.